|Articles|July 13, 2022

Signant Health Enhances Randomization and Trial Supply Management (RTSM) Platform

RTSM solution now offers additional benefits with the delivery of study supplies to patients' homes.

Signant Health has announced enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution.

The enhancements to Signant's RTSM solution enable secure and encrypted storage of patient shipment addresses, integration with depot/central pharmacy ordering systems, and courier status reporting.

Read more about the platform here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content